InvestorsHub Logo

GinGinGin

05/06/22 12:01 PM

#466885 RE: The Danish Dude #466869

So far none of my investments have unfolded as anticipated, CVM being one of them.

I expect some twists with NWBO's results. For example the original primary endpoint may fail, but the new one would pass - this will give pessimists an opportunity to bring down the share price albeit temporarily followed by an eventual surge.

Another example would see both primary endpoints fail but as with CVM a meaningful subgroup with tremendous success would be identified. Again, that would drop the sp temporarily.

I do hope for the most optimistic scenario of nailing both old and new primary endpoints but simply being cautious now in order not to get disappointed too much.

Ultimately, I am absolutely certain that DCVax will reach the market, the question is how quickly and how big will the market be.